Open access · CC-BY
via OpenAlex
IGF-1 receptor antagonism inhibits autophagy
Maurizio Renna, Carla F. Bento, Angeleen Fleming, Fiona M. Menzies, Farah H. Siddiqi, Brinda Ravikumar, Claudia Puri, Moisés Garcı́a-Arencibia, Oana Sadiq, Silvia Corrochano, Sarah Carter, Steve D. M. Brown, Abraham Acevedo‐Arozena, David Chaim Rubinsztein
Human Molecular Genetics · 2013 · ▲ 89 citations
Deregulated nutrient-sensing
Disabled macroautophagy
Partial reprogramming (OSK)
Human
Zebrafish
Mouse
Abstract
Inhibition of the insulin/insulin-like growth factor signalling pathway increases lifespan and protects against neurodegeneration in model organisms, and has been considered as a potential therapeutic target. This pathway is upstream of mTORC1, a negative regulator of autophagy(definition). Thus, we expected autophagy to be activated by insulin-like growth factor-1 (IGF-1) inhibition, which could account for many of its beneficial effects. Paradoxically, we found that IGF-1 inhibition attenuates autophagosome formation. The reduced amount of autophagosomes present in IGF-1R depleted cells can be, at least in part, explained by a reduced formation of autophagosomal precursors at the plasma membrane. In particular, IGF-1R depletion inhibits mTORC2, which, in turn, reduces the activity of protein kinase C (PKCα/β). This perturbs the actin cytoskeleton dynamics and decreases the rate of clathrin-dependent endocytosis, which impacts autophagosome precursor formation. Finally, with important implications for human diseases, we demonstrate that pharmacological inhibition of the IGF-1R signalling cascade reduces autophagy also in zebrafish and mice models. The novel link we describe here has important consequences for the interpretation of genetic experiments in mammalian systems and for evaluating the potential of targeting the IGF-1R receptor or modulating its signalling through the downstream pathway for therapeutic purposes under clinically relevant conditions, such as neurodegenerative diseases, where autophagy stimulation is considered beneficial.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/hmg/ddt300
- Canonical
- link ↗
- Fetched
- 2026-10-22 MST
Cite this
APA
Renna, M., Bento, C.F., Fleming, A., Menzies, F.M., Siddiqi, F.H., Ravikumar, B., Puri, C., Garcı́a-Arencibia, M., Sadiq, O., Corrochano, S., Carter, S., Brown, S.D.M., Acevedo‐Arozena, A., & Rubinsztein, D.C. (2013). IGF-1 receptor antagonism inhibits autophagy. <em>Human Molecular Genetics</em>. https://doi.org/10.1093/hmg/ddt300
Vancouver
Renna M, Bento CF, Fleming A, Menzies FM, Siddiqi FH, Ravikumar B, et al. IGF-1 receptor antagonism inhibits autophagy. Human Molecular Genetics. 2013. doi:10.1093/hmg/ddt300.
BibTeX
@article{maurizio2013IGFrec,
title = {IGF-1 receptor antagonism inhibits autophagy},
author = {Maurizio Renna and Carla F. Bento and Angeleen Fleming and Fiona M. Menzies and Farah H. Siddiqi and Brinda Ravikumar and Claudia Puri and Moisés Garcı́a-Arencibia and Oana Sadiq and Silvia Corrochano and Sarah Carter and Steve D. M. Brown and Abraham Acevedo‐Arozena and David Chaim Rubinsztein},
journal = {Human Molecular Genetics},
year = {2013},
doi = {10.1093/hmg/ddt300},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Genetics 2012
Open access · CC-BY
Rapamycin has a biphasic effect on insulin sensitivity in C2C12 myotubes due to sequential disruption of mTORC1 and mTORC2
Nature Communications 2019
Open access · CC-BY
A novel rapamycin analog is highly selective for mTORC1 in vivo
Laboratory Investigation 2015
Open access · OA
Sirtuin 1 promotes the growth and cisplatin resistance of endometrial carcinoma cells: a novel therapeutic target
Antioxidants 2024
Open access · CC-BY
Butein Increases Resistance to Oxidative Stress and Lifespan with Positive Effects on the Risk of Age-Related Diseases in Caenorhabditis elegans
MDPI eBooks 2019
Open access · CC-BY
Benefits of Resveratrol Supplementation
Biochemical Journal 2008
Open access · OA